They are:
1. A dual-acting osteoporosis drug, romosozumab, recently approved by the FDA, provides bone strength.
2. Closed-loop spinal cord stimulation can help patients suffering chronic pain. Implantable devices allowing for closed-loop stimulation are creating better communication between the spinal cord and device, making the procedure more effective.
3. Biologics in orthopedic repair are helping patients recover faster using natural substances, such as cells and blood components.
More articles on spine:
Spinal cord stimulation device market to grow at 7.5% CAGR through 2025 — 3 insights
Life Spine, executives to settle FCA allegations for nearly $6M
Drs. Todd Lanman, Gornet Matthew publish follow-up data on 2-level cervical disc replacement
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.